Lotfi Benboubker

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

Thomas Dejoie, Jill Corre, Hélène Caillon et al. · Blood · 2016 · 69 citations · Full text

<i>CXCL12</i> polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia

Florence Dommange, Guillaume Cartron, Claire Espanel et al. · The FASEB Journal · 2006 · 59 citations

Hematological Malignancy, Receptor Cxcr4, Medicine +14

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Hervé Avet‐Loiseau, Jill Corre, Valérie Lauwers‐Cancès et al. · Blood · 2015 · 56 citations

Stromal‐derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony‐stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells

Alexandra Carion, Lotfi Benboubker, Olivier Hérault et al. · British Journal of Haematology · 2003 · 43 citations · Full text

Frontline Therapy with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Induction Followed By Autologous Stem Cell Transplantation, Krd Consolidation and Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM) Patients: Primary Results of the Intergroupe Francophone Du MyéLome (IFM) Krd Phase II Study

Murielle Roussel, Valérie Lauwers‐Cancès, Nelly Robillard et al. · Blood · 2016 · 42 citations